Primary Record
Daunorubicinol
- In stock
- 5,344 g
- Purity
- 98.7 %
- CAS
- 28008-55-1
Compound Identifiers & Properties
- CAS
- 28008-55-1
- PubChem CID
- 443832
- SMILES
- C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)([C@H](C)O)O)N)O
- Canonical SMILES
- COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)([C@H](C)O)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1
Names & Synonyms
- Daunorubicinol
- Daunomycinol
- Duborimycin
- Leukaemomycin D
- Dihydrodaunomycin
- 13-Dihydrodaunomycin
- 13-Dihydrodaunorubicin
- Antibiotic 20-798RP
- YDU8YIP30L
- (13S)-13-Dihydrodaunorubicin
- UNII-YDU8YIP30L
- AC1L9FAF
- Daunorubicinol Impurity B
- RefChem:131005
- daunorubicinol hydrochloride
- 28008-55-1
- Daunorubicin EP Impurity B
- 1-Hydroxy-13-dihydrodaunomycin
- C27H31NO10
- orb1986228
- SCHEMBL30662192
- CHEBI:31031
- BRN 3641654
- CID443832
- LMPK13050005
- AKOS027326518
- C27-H31-N-O10
- MD32003
- Daunorubicin Impurity B ((1S)-isomer)
- Daunorubicinol (Mixture of Diastereomers)
- J86.140E
- FT-0701353
- C12433
- Q27114084
- (7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-[(1S)-1-hydroxyethyl]-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione
- B0709-469824
- (8S,10S)-10-(((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-8-((S)-1-hydroxyethyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione
- 5,12-Naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-((1S)-1-hydroxyethyl)-1-methoxy-, (8S,10S)-
- (1S,3S)-3,5,12-trihydroxy-3-[(1S)-1-hydroxyethyl]-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside
- (7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-6,9,11-trihydroxy-9-[(1S)-1-hydroxyethyl]-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione
- (8S)-1-Methoxy-6,8,11-trihydroxy-8beta-[(S)-1-hydroxyethyl]-10alpha-(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyloxy)-7,8,9,10-tetrahydronaphthacene-5,12-dione
- (8S)-7,8,9,10-Tetrahydro-10alpha-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-8-[(S)-1-hydroxyethyl]-1-methoxy-6,8alpha,11-trihydroxy-5,12-naphthacenedione
- (8S,10S)-10-{[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy}-6,8,11-trihydroxy-8-[(1S)-1-hydroxyethyl]-1-methoxy-5,7,8,9,10,12-hexahydrotetracene-5,12-dione
- 5,12-NAPHTHACENEDIONE, 10-((3-AMINO-2,3,6-TRIDEOXY-.ALPHA.-L-LYXO-HEXOPYRANOSYL)OXY)-7,8,9,10-TETRAHYDRO-6,8,11-TRIHYDROXY-8-((1S)-1-HYDROXYETHYL)-1-METHOXY-, (8S,10S)-
- 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(1-hydroxyethyl)-1-methoxy-
- 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-[(1S)-1-hydroxyethyl]-1-methoxy-, (8S,10S)-
- 5,12-Naphthacenedione, 7,8,9,10-tetrahydro-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxohexopyranosyl)oxy)-8-(1-hydroxyethyl)-1-methoxy-6,8,11-trihydroxy-
- 7,8,9,10-tetrahydro-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxohexopyranosyl)oxy)-8-(1-hydroxyethyl)-1-methoxy-6,8,11-trihydroxy-5,12-Naphthacenedione
- L-lyxo-Hexopyranoside, 1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-3-(1-hydroxyethyl)-10-methoxy-6,11-dioxo-1-naphthacenyl 3-amino-2,3,6-trideoxy-, (1S,3S)- .alpha.-